Search Results - "Webster, Kimberly A."

Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria by Peipert, John Devin, Kulasekararaj, Austin G., Gaya, Anna, Langemeijer, Saskia M. C., Yount, Susan, Gonzalez-Fernandez, F. Ataulfo, Ojeda Gutierrez, Emilio, Martens, Christa, Sparling, Amy, Webster, Kimberly A., Cella, David, Tomazos, Ioannis, Ogawa, Masayo, Piatek, Caroline I., Wells, Richard, Sicre de Fontbrune, Flore, Röth, Alexander, Mitchell, Lindsay, Hill, Anita, Kaiser, Karen

“…Background Eculizumab has transformed management of paroxysmal nocturnal hemoglobinuria (PNH) since its approval. However, its biweekly dosing regimen remains…”
Get full text

Protocol for a type 2 hybrid effectiveness-implementation study expanding, implementing and evaluating electronic health record-integrated patient-reported symptom monitoring in a multisite cancer centre by Garcia, Sofia F, Smith, Justin D, Kallen, Michael, Webster, Kimberly A, Lyleroehr, Madison, Kircher, Sheetal, Bass, Michael, Cella, David, Penedo, Frank J

“…IntroductionCancer symptom monitoring and management interventions can address concerns that may otherwise go undertreated. However, such programmes and their…”
Get full text

Content validation of the National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Lymphoma Symptom Index-18 (NFLymSI-18) in indolent B-cell non-Hodgkin’s lymphoma by Hurt, Courtney N., Kaiser, Karen, Shaunfield, Sara, Webster, Kimberly A., Keating, Karen, Boyken, Lara, Duffey, Sara, Garcia, Jessica, Cella, David

“…Background The NFLymSI-18 is a patient-reported outcome measure comprised of the highest priority symptoms, emotional concerns, treatment side effects, and…”
Get full text

A mixed methods evaluation of patient perspectives on the implementation of an electronic health record-integrated patient-reported symptom and needs monitoring program in cancer care by Lyleroehr, Madison J., Webster, Kimberly A., Perry, Laura M., Patten, Elijah A., Cantoral, Jackelyn, Smith, Justin D., Cella, David, Penedo, Frank J., Garcia, Sofia F.

“…Background As cancer centers have increased focus on patient-centered, evidenced-based care, implementing efficient programs that facilitate effective…”
Get full text

Risk of significant functional impairment across cancer diagnosis and care continuum by Flores, Ann Marie, Shah, Mitisha, Bedjeti, Katy, Franklin, Patricia D, Peipert, John Devin, Garcia, Sofia F, Lancki, Nicola, Webster, Kimberly A, O'Connor, Mary, Cella, David

“…The authors examined baseline physical functional (PF) impairment among cancer outpatients in the National Cancer Institute Cancer Moonshot study Northwestern…”
Get full text

Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom Index by Shaunfield, Sara, Webster, Kimberly A, Kaiser, Karen, Greene, George J, Yount, Susan E, Lacson, Leilani, Benson, Al B, Halperin, Daniel M, Yao, James C, Singh, Simron, Feuilly, Marion, Marteau, Florence, Cella, David

“…To develop a symptom-focused index to evaluate representative symptoms, treatment side effects, and emotional and functional well-being of patients with…”
Get more information

Tracking dynamic changes in implementation strategies over time within a hybrid type 2 trial of an electronic patient-reported oncology symptom and needs monitoring program by Smith, Justin D, Merle, James L, Webster, Kimberly A, Cahue, September, Penedo, Frank J, Garcia, Sofia F

“…Longitudinal tracking of implementation strategies is critical in accurately reporting when and why they are used, for promoting rigor and reproducibility in…”
Get full text

Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG‐ACRIN Cancer Research Group (E1302) by Oswald, Laura B., Lee, Ju‐Whei, Argiris, Athanassios, Webster, Kimberly A., Forastiere, Arlene A., Cella, David

“…Background Patients with advanced head and neck cancer have identified pain, fatigue, and difficulties swallowing, breathing, and communicating as…”
Get full text

Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ © ) by Kaiser, Karen, Yount, Susan E, Martens, Christa E, Webster, Kimberly A, Shaunfield, Sara, Sparling, Amy, Peipert, John Devin, Cella, David, Rottinghaus, Scott T, Donato, Bonnie M K, Wells, Richard, Tomazos, Ioannis

“…To develop a patient preference questionnaire (PPQ) assessing eculizumab and ravulizumab treatment for paroxysmal nocturnal hemoglobinuria (PNH). The…”
Get full text

Measuring the concerns of cancer patients with low platelet counts: the Functional Assessment of Cancer Therapy--thrombocytopenia (FACT-Th) questionnaire by Cella, David, Beaumont, Jennifer L, Webster, Kimberly A, Lai, Jin-Shei, Elting, Linda

“…The specific concerns of people with low platelet counts (thrombocytopenia) have not been characterized well in the literature and as a result proper…”
Get full text

Patient preferences and quality of life implications of ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria by Peipert, John Devin, Kulasekararaj, Austin G, Gaya, Anna, Langemeijer, Saskia M. C, Yount, Susan, Gonzalez-Fernandez, F. Ataulfo, Ojeda Gutierrez, Emilio, Martens, Christa, Sparling, Amy, Webster, Kimberly A, Cella, David, Tomazos, Ioannis, Ogawa, Masayo, Piatek, Caroline I, Wells, Richard, Sicre de Fontbrune, Flore, Röth, Alexander, Mitchell, Lindsay, Hill, Anita, Kaiser, Karen

“…Background Eculizumab has transformed management of paroxysmal nocturnal hemoglobinuria (PNH) since its approval. However, its biweekly dosing regimen remains…”
Get full text

Patient preferences and quality of life implications of ravulizumab by Peipert, John Devin, Kulasekararaj, Austin G, Gaya, Anna, Langemeijer, Saskia M. C, Yount, Susan, Gonzalez-Fernandez, F. Ataulfo, Ojeda Gutierrez, Emilio, Martens, Christa, Sparling, Amy, Webster, Kimberly A, Cella, David, Tomazos, Ioannis, Ogawa, Masayo, Piatek, Caroline I, Wells, Richard, Sicre de Fontbrune, Flore, Röth, Alexander, Mitchell, Lindsay, Hill, Anita, Kaiser, Karen

“…Background Eculizumab has transformed management of paroxysmal nocturnal hemoglobinuria (PNH) since its approval. However, its biweekly dosing regimen remains…”
Get full text

Measuring Health-Related Quality of Life in Leukemia: The Functional Assessment of Cancer Therapy – Leukemia (FACT-Leu) Questionnaire by Cella, David, PhD, Jensen, Sally E., PhD, Webster, Kimberly, MA, Hongyan, Du, MS, Lai, Jin-Shei, PhD, Rosen, Steven, MD, Tallman, Martin S., MD, Yount, Susan, PhD

“…ABSTRACT Objective Develop and validate a health-related quality-of-life (measure for patients with acute and chronic leukemia. Methods The study consisted of…”
Get full text

Symptom and needs assessment screening in oncology patients: Alternate outreach methods during COVID-19 by Davis, Kristina, Wilbur, Kayla, Metzger, Susan, Garcia, Sofia F., Cahue, September, Webster, Kimberly, Lylerohr, Madison, Himelhoch, Heather L., Bilimoria, Karl, Cella, David

“…Patients with cancer are ideally screened for symptoms, including distress, using patient-reported outcome measures (PROMs). This initiative was developed to…”
Get full text

Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions by Hahn, Elizabeth A., Webster, Kimberly A., Cella, David, Fairclough, Diane L.

“…Incorporation of quality of life (QOL) investigation into Eastern Cooperative Oncology Group (ECOG) multi‐centre clinical trials has led to innovative…”
Get full text

Rehabilitation Needs of Patients with Oropharyngeal Cancer by Tippett, Donna C., MPH, MA, CCC-SLP, Webster, Kimberly T., MA, MS, CCC-SLP

“…Swallowing and swallowing-related impairments present important posttreatment challenges in individuals undergoing organ preservation therapy for head and neck…”
Get full text

Effects of Laryngeal Cancer on Voice and Swallowing by Starmer, Heather M., MA, CCC-SLP, Tippett, Donna C., MPH, MA, CCC-SLP, Webster, Kimberly T., MA, MS, CCC-SLP

“…Specific deficits that may be encountered as well as interventional strategies and evidence-based practice are discussed. When discussing the voice, it is…”
Get full text